SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-019242
Filing Date
2017-11-14
Accepted
2017-11-14 10:01:50
Documents
41
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q relv20170930_10q.htm 10-Q 818780
2 EXHIBIT 31.1 ex_100125.htm EX-31.1 15454
3 EXHIBIT 31.2 ex_100126.htm EX-31.2 15184
4 EXHIBIT 32 ex_100127.htm EX-32 7020
  Complete submission text file 0001437749-17-019242.txt   2714386

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT relv-20170930.xml EX-101.INS 361017
6 XBRL TAXONOMY EXTENSION SCHEMA relv-20170930.xsd EX-101.SCH 24003
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE relv-20170930_cal.xml EX-101.CAL 44125
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE relv-20170930_def.xml EX-101.DEF 189501
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE relv-20170930_lab.xml EX-101.LAB 173718
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE relv-20170930_pre.xml EX-101.PRE 201034
Mailing Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405
Business Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405 636-537-9715
RELIV INTERNATIONAL INC (Filer) CIK: 0000768710 (see all company filings)

IRS No.: 371172197 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19932 | Film No.: 171198911
SIC: 2834 Pharmaceutical Preparations